About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Headache Inducing Effect of NN414 in Migraine Patients

NCT04744129·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Danish Headache Center

Age

18–60

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Criteria
Migraine patients of both sexes.
18-60 years.
50-100 kg.
Women of childbearing potential must use adequate contraception.

You may not be if

Headache less than 48 hours before the tests start
Daily consumption of drugs of any kind other than oral contraceptives
Pregnant or nursing women.
Cardiovascular disease of any kind, including cerebrovascular diseases.
Diabetes mellitus and other endocrinologic disease

The record

StatusUnknown

PhaseNo phase

Taking part16

StartedFeb 2022

UpdatedFeb 13, 2023

Conditions

Headache, Migraine

Where1

Danish Headache Center
Copenhagen, Capital Region, Denmark

Clareo Health | Headache Inducing Effect of NN414 in Migraine Patients